4.7 Article

Morbid Obesity Is Associated With Adverse Clinical Outcomes in Acute Pancreatitis: A Propensity-Matched Study

期刊

AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 110, 期 11, 页码 1607-1620

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1038/ajg.2015.343

关键词

-

向作者/读者索取更多资源

OBJECTIVES: Morbid obesity may adversely affect the clinical course of acute pancreatitis (AP); however, there are no inpatient, population-based studies assessing the impact of morbid obesity on AP-related outcomes. We sought to evaluate the impact of morbid obesity on AP-related clinical outcomes and health-care utilization. METHODS: The Nationwide Inpatient Sample (2007-2011) was reviewed to identify all adult inpatients (>= 18 years) with a principal diagnosis of AP. The primary clinical outcomes (mortality, renal failure, and respiratory failure) and secondary resource outcomes (length of stay and hospital charges) were analyzed using univariate and multivariate comparisons. Propensity score-matched analysis was performed to compare the outcomes in patients with and without morbid obesity. RESULTS: Morbid obesity was associated with 3.9% (52,297/1,330,302) of all AP admissions. Whereas the mortality rate decreased overall (0.97%-> 0.83%, P < 0.001), it remained unchanged in those with morbid obesity (1.02%. 1.07%, P = 1.0). Multivariate analysis revealed that morbid obesity was associated with increased mortality (odds ratio (OR) 1.6; 95% confi dence interval (CI) 1.3, 1.9), prolonged hospitalization (0.4 days; P < 0.001), and higher hospitalization charges ($ 5,067; P < 0.001). A propensity score-matched cohort analysis demonstrated that the primary outcomes, acute kidney failure (10.8 vs. 8.2%; P < 0.001), respiratory failure (7.9 vs. 6.4%; P < 0.001), and mortality (OR 1.6, 95% CI 1.2, 2.1) were more frequent in morbid obesity. CONCLUSIONS: Morbid obesity negatively influences inpatient hospitalization and is associated with adverse clinical outcomes, including mortality, organ failure, and health-care resource utilization. These observations and the increasing global prevalence of obesity justify ongoing efforts to understand the role of obesity-induced inflammation in the pathogenesis and management of AP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据